Tendencias21

Age shouldn’t limit access to transplants for MDS, study suggests

Patients with myelodysplastic syndromes who were as old as 74 fared as well with stem cell transplantation as did patients in the 60-to-65 age range, according to a study from Dana-Farber Cancer Institute presented at the annual meeting of the American Society of Hematology.

Fuente : http://www.eurekalert.org/pub_releases/2013-12/dci…

RedacciónT21

RedacciónT21

Hacer un comentario